Anticancer Properties of Eugenol: A Review

Area of Science:

• Phytochemistry
• Pharmacology
• Oncology

Background:

• Conventional cancer therapies face challenges like adverse effects and drug resistance.
• Natural products, particularly from medicinal plants, are gaining attention for anticancer properties.
• Clove (Syzygium aromaticum) is a spice rich in phenolics, with eugenol being a key bioactive component.

Purpose of the Study:

• To review the anticancer properties of eugenol, a principal component of clove.
• To explore the diverse mechanisms by which eugenol exerts its anticancer effects.
• To assess the potential of eugenol as an adjunct therapy in cancer treatment.

Main Methods:

• Literature review focusing on studies investigating eugenol's anticancer activities.
• Analysis of research on eugenol's mechanisms of action, including cell death induction and cell cycle arrest.
• Examination of studies on eugenol's effects on cancer cell migration, metastasis, and angiogenesis.

Main Results:

• Eugenol demonstrates broad-spectrum anticancer effects across various cancer cell lines.
• Mechanisms include induction of apoptosis, cell cycle arrest, and inhibition of metastasis and angiogenesis.
• Eugenol shows potential as an adjunct therapy, enhancing chemotherapy efficacy while reducing toxicity.

Conclusions:

• Eugenol possesses significant anticancer properties attributed to its multifaceted biological activities.
• Its ability to target multiple cancer hallmarks makes it a promising candidate for cancer therapy.
• Further research into eugenol's therapeutic potential, especially in combination therapies, is warranted.